Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00334438
Status:
COMPLETED
Last Update Posted:
2016-12-23
First Post:
2006-06-06
Brief Title:
Bortezomib Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade Follicular or Mantle Cell Non-Hodgkins Lymphoma
Sponsor:
Organization:
UNC Lineberger Comprehensive Cancer Center